Post-tuberculosis lung health: perspectives from the First International Symposium
- PMID: 32912387
- DOI: 10.5588/ijtld.20.0067
Post-tuberculosis lung health: perspectives from the First International Symposium
Abstract
ALTHOUGH CURABLE, TB frequently leaves the individual with chronic physical and psycho-social impairment, but these consequences have been largely neglected. The 1st International Post-Tuberculosis Symposium (Stellenbosch, South Africa) was held to discuss priorities and gaps in addressing this issue. A barrier to progress has been the varied terminology and nomenclature, so the Delphi process was used to achieve consensus on definitions. Lack of sufficient evidence hampered definitive recommendations in most domains, including prevention and treatment of post-TB lung disease (PTLD), but the discussions clarified the research needed. A consensus was reached on a toolkit for future PTLD measurement and on PTLD patterns to be considered. The importance of extra-pulmonary consequences and progressive impairment throughout the life-course was identified, including TB recurrence and increased mortality. Patient advocates emphasised the need to address the psychological and social impacts post TB and called for clinical guidance. More generally, there is an urgent need for increased awareness and research into post-TB complications.
Comment in
-
Post-tuberculosis sequelae: the need to look beyond treatment outcome.Int J Tuberc Lung Dis. 2020 Aug 1;24(8):761-762. doi: 10.5588/ijtld.20.0488. Int J Tuberc Lung Dis. 2020. PMID: 32912378 No abstract available.
-
Taking action to improve post-TB lung health.Int J Tuberc Lung Dis. 2021 Feb 1;25(2):161-162. doi: 10.5588/ijtld.20.0861. Int J Tuberc Lung Dis. 2021. PMID: 33656433 No abstract available.
-
Reply to: Taking action to improve post-TB lung health.Int J Tuberc Lung Dis. 2021 Feb 1;25(2):163a-163. doi: 10.5588/ijtld.20.0902. Int J Tuberc Lung Dis. 2021. PMID: 33656434 No abstract available.
-
Clinical care for patients with post-TB lung disease.Int J Tuberc Lung Dis. 2021 Mar 1;25(3):252-253. doi: 10.5588/ijtld.20.0824. Int J Tuberc Lung Dis. 2021. PMID: 33688820 No abstract available.
-
Reply to "Clinical care for patients with post TB lung disease".Int J Tuberc Lung Dis. 2021 Mar 1;25(3):253-254. doi: 10.5588/ijtld.20.0903. Int J Tuberc Lung Dis. 2021. PMID: 33688821 No abstract available.
Similar articles
-
Perspectives from the 2nd International Post-Tuberculosis Symposium: mobilising advocacy and research for improved outcomes.IJTLD Open. 2024 Mar 1;1(3):111-123. doi: 10.5588/ijtldopen.23.0619. eCollection 2024 Mar. IJTLD Open. 2024. PMID: 38966406 Free PMC article.
-
Post-tuberculosis lung disease in children and adolescents: A scoping review of definitions, measuring tools, and research gaps.Paediatr Respir Rev. 2025 Mar;53:55-63. doi: 10.1016/j.prrv.2024.07.001. Epub 2024 Jul 18. Paediatr Respir Rev. 2025. PMID: 39129097
-
Post-TB health and wellbeing.Int J Tuberc Lung Dis. 2023 Apr 1;27(4):248-283. doi: 10.5588/ijtld.22.0514. Int J Tuberc Lung Dis. 2023. PMID: 37035971 Free PMC article.
-
Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-implementation study protocol.BMC Pulm Med. 2024 Oct 10;24(1):502. doi: 10.1186/s12890-024-03329-7. BMC Pulm Med. 2024. PMID: 39390443 Free PMC article.
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
Cited by
-
Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hypertension.Pulm Circ. 2023 Apr 1;13(2):e12213. doi: 10.1002/pul2.12213. eCollection 2023 Apr. Pulm Circ. 2023. PMID: 37025209 Free PMC article. Review.
-
Type and physical intensity of occupations at pulmonary TB diagnosis.IJTLD Open. 2025 Jan 1;2(1):39-44. doi: 10.5588/ijtldopen.24.0323. eCollection 2025 Jan. IJTLD Open. 2025. PMID: 39802233 Free PMC article.
-
Tuberculosis-Associated Respiratory Disability in Children, Adolescents, and Adults: Protocol for a Systematic Review and Individual Participant Data Meta-Analysis.medRxiv [Preprint]. 2024 Sep 4:2024.09.03.24313003. doi: 10.1101/2024.09.03.24313003. medRxiv. 2024. Update in: BMJ Open. 2025 Mar 24;15(3):e094118. doi: 10.1136/bmjopen-2024-094118. PMID: 39281764 Free PMC article. Updated. Preprint.
-
Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease.J Bras Pneumol. 2024 Jan 5;49(6):e20230269. doi: 10.36416/1806-3756/e20230269. eCollection 2024. J Bras Pneumol. 2024. PMID: 38198346 Free PMC article.
-
Perceptions and clinical practices associated with post-TB health and well-being in the Netherlands.IJTLD Open. 2024 Oct 1;1(10):480-482. doi: 10.5588/ijtldopen.24.0377. eCollection 2024 Oct. IJTLD Open. 2024. PMID: 39398439 Free PMC article. No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical